Preliminary results from an MRI/CT-based database for vascular dementia and Alzheimer's disease

Annals of the New York Academy of Sciences

Volumn 903, Issue , 2000, Pages 542-546

  Scheltens, Philip ^a   Kittner, Barbara ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; HUMAN; MAJOR CLINICAL STUDY; MULTIINFARCT DEMENTIA; NUCLEAR MAGNETIC RESONANCE IMAGING; RANDOMIZED CONTROLLED TRIAL;

EID: 0034023914     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06411.x     Document Type: Conference Paper

References (11)

1. 1. SCHELTENS, P., D. LEYS, F. BARKHOF et al. 1992. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal aging: diagnostic value and neuropsychological correlates. J. Neurol. Neurosurg. Psychiatry 55: 967-972.
2. 2. ROMÁN, G.C., T.K. TATEMICHI, T. ERKINJUNTTI et al. 1993. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Work Group. Neurology 43: 250-260.
3. 3. TIERNEY, M.C., R.H. FISHER, A.J. LEWIS et al. 1988. The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinico-pathological study of 57 cases. Neurology 38: 359-364.
4. 4. SCHELTENS, P., F. BARKHOF, J. VALK et al. 1992. White matter lesions on magnetic resonance imaging in Alzheimer's disease: evidence for heterogeneity. Brain 115: 735-743.
5. 5. SNOWDON, D.A., L.H. GREINER, J.A. MORTIMER et al. 1997. Brain infarction and the clinical expression of Alzheimer's disease: the Nun Study. JAMA. 277: 813-817.
6. 6. PASQUIER, F., D. LEYS & P.H. SCHELTENS. 1998. The influence of coincidental vascular pathology on symptomatology and course of Alzheimer's disease. J. Neural. Transm. 54: 117-129.
7. 7. MCKHANN, G., D. DRACHMAN, M. FOLSTEIN et al. 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ARDRA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-944.
8. 8. SCHELTENS, P., F. PASQUIER, J.G. WEERTS et al. 1997. Qualitative assessment of cerebral atrophy on MRI: inter-and intra-observer reproducibility in dementia and normal aging. Eur. Neurol. 37: 95-99.
9. 9. DE LEON, M.J., A.E. GEORGE, L.A. STYLOPOULOS et al. 1989. Early marker for Alzheimer's disease: the atrophic hippocampus. Lancet II: 672-673.
10. 10. BLENNOW, K., A. WALLIN, C. UHLEMANN et al. 1991. White-matter lesions on CT in Alzheimer's patients: relation to clinical symptomatology and vascular factors. Acta Neurol. Scand. 83: 187-193.
11. 11. SCHELTENS, P., F. BARKHOF, D. LEYS et al. 1993. A semiquantitative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J. Neurol. Sci. 114: 7-12.